Clinical Trial Update: Administration of Oral Extended Release Minocycline for Assessment of Skin and Plasma Concentrations of Minocycline [Phase 4]

View source ↗

Summary

Phase 4 trial assessing skin and plasma concentrations of oral extended-release minocycline in acne patients; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne

Drugs mentioned

• Minocycline Extended Release (oral) (minocycline)

Snippet

Sponsor: BioPharmX, Inc. | Conditions: Acne | Phase 4 | Status: COMPLETED | Results posted: 2017-09-14